Eli Lilly

Eli Lilly is a major pharmaceutical company currently in the news due to several key developments. The company recently received FDA approval in the US for its new weight-loss pill, Orforglipron (brand name Foundayo), leading to a rise in its stock price. Clinical trials showed significant weight loss in obese adults using the pill. This approval positions Eli Lilly to capitalize on the growing market for weight-loss medications. However, the company also faces potential challenges. The US government, under Donald Trump, is threatening tariffs of up to 100% on pharmaceutical companies that don't lower drug prices or manufacture in the US. This could impact Eli Lilly's operations and profitability, particularly in Europe. Furthermore, the company is seeing increased demand for weight-loss drugs like Mounjaro, even for cosmetic purposes such as pre-wedding weight loss in countries like India. Eli Lilly also recently acquired sleep-aid company Centessa for billions.